CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 
 

XFOR's EPS from Cont. Operations Growth by Quarter and Year

X4 Pharmaceuticals Inc's EPS from Cont. Operations results by quarter and year




XFOR EPS from Cont. Operations (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - -0.01 -0.26 -0.76
III Quarter September - -0.33 -0.60 -0.74
II Quarter June - -0.16 -0.72 -1.30
I Quarter March -0.26 -0.29 -1.23 -0.91
FY   -0.26 -0.79 -2.81 -3.71



XFOR EPS from Cont. Operations first quarter 2024 Y/Y Growth Comment
X4 Pharmaceuticals Inc in the first quarter 2024 recorded EPS loss from Cont. Operations of $ -0.26 .

According to the results reported in the first quarter 2024, X4 Pharmaceuticals Inc achieved the best EPS from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While X4 Pharmaceuticals Inc' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the first quarter 2024.




XFOR EPS from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
X4 Pharmaceuticals Inc's first quarter 2024 EPS from Cont. Operations $ -0.26 XFOR's Income Statement
X4 Pharmaceuticals Inc's first quarter 2023 EPS from Cont. Operations $ -0.29 Quarterly XFOR's Income Statement
New: More XFOR's historic EPS from Cont. Operations Growth >>


XFOR EPS from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

X4 Pharmaceuticals Inc's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's I. Quarter Q/Q EPS from Cont. Operations Comment
I. Quarter 2024 results of -0.26 by X4 Pharmaceuticals Inc come out even worse considering the -0.01 EPS loss from Cont. Operations in the previous quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential EPS from Cont. Operations growth. While X4 Pharmaceuticals Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's I. Quarter Q/Q EPS from Cont. Operations Comment
I. Quarter 2024 EPS loss from Cont. Operations of -0.26 by X4 Pharmaceuticals Inc come out even more unfavourable if you take a look at -0.01 EPS loss from Cont. Operations a quarter before.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential EPS from Cont. Operations growth. While X4 Pharmaceuticals Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is .


X4 Pharmaceuticals Inc's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.76 $ -0.79 $ -1.04 $ -1.31 $ -1.87
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


X4 Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


X4 Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
XFOR's EPS from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for XFOR's Competitors
EPS from Cont. Operations Growth for X4 Pharmaceuticals Inc's Suppliers
EPS from Cont. Operations Growth for XFOR's Customers

You may also want to know
XFOR's Annual Growth Rates XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2024
Mettler Toledo International Inc-2.93%$ -2.931 
Quest Diagnostics Inc-3.33%$ -3.333 
National Research Corporation-3.57%$ -3.571 
Cadre Holdings inc -5.26%$ -5.263 
Progyny Inc -5.26%$ -5.263 
3m Company-5.65%$ -5.650 
Utah Medical Products Inc-6.03%$ -6.034 
Abbott Laboratories-6.67%$ -6.667 
Regeneron Pharmaceuticals Inc -12.30%$ -12.304 
Phibro Animal Health Corporation-16.00%$ -16.000 
West Pharmaceutical Services Inc -16.49%$ -16.489 
Sonida Senior Living Inc -19.44%$ -19.444 
Atrion Corporation-19.70%$ -19.697 
U S Physical Therapy Inc-20.69%$ -20.690 
Baxter International Inc -22.22%$ -22.222 
Catalyst Pharmaceuticals Inc -28.57%$ -28.571 
American Shared Hospital Services-33.33%$ -33.333 
Entera Bio Ltd -37.50%$ -37.500 
Amedisys Inc-43.59%$ -43.590 
Viatris Inc -47.37%$ -47.368 
Envista Holdings Corporation-48.15%$ -48.148 
Pro dex Inc -48.65%$ -48.649 
Avantor Inc -50.00%$ -50.000 
Oramed Pharmaceuticals Inc -50.00%$ -50.000 
Privia Health Group Inc -50.00%$ -50.000 
Dariohealth Corp -55.56%$ -55.556 
Orgenesis Inc -66.67%$ -66.667 
Elanco Animal Health Inc-71.43%$ -71.429 
Agilon Health Inc -75.00%$ -75.000 
Royalty Pharma Plc-98.68%$ -98.684 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com